Literature DB >> 3105140

Use of Orthoclone OKT3 monoclonal antibody in cardiac transplantation: early experience with rejection prophylaxis and treatment of refractory rejection.

E M Gilbert, C C Eiswirth, D G Renlund, R L Menlove, C W DeWitt, L A Freedman, C M Herrick, W A Gay, M R Bristow.   

Abstract

Mesh:

Substances:

Year:  1987        PMID: 3105140

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  7 in total

1.  Infections in pediatric liver recipients treated for acute rejection.

Authors:  B Koneru; V P Scantlebury; L Makowka; C O Esquivel; S Todo; A G Tzakis; J W Marsh; S Iwatsuki; L Douglas; T E Starzl
Journal:  Transplant Proc       Date:  1989-02       Impact factor: 1.066

Review 2.  Cardiac transplantation--the need for prospective, randomized, controlled investigations.

Authors:  D G Renlund; M R Bristow; J B O'Connell
Journal:  West J Med       Date:  1988-11

Review 3.  Muromonab CD3. A review of its pharmacology and therapeutic potential.

Authors:  P A Todd; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

4.  OKT3 monoclonal antibody in cardiac transplantation. Experience with 102 patients.

Authors:  W A Gay; J G O'Connell; N A Burton; S V Karwande; D G Renlund; M R Bristow
Journal:  Ann Surg       Date:  1988-09       Impact factor: 12.969

Review 5.  Drug management of the cardiac transplant patient.

Authors:  S A Hunt
Journal:  Cardiovasc Drugs Ther       Date:  1988-12       Impact factor: 3.727

6.  Use of OKT3 monoclonal antibody as induction therapy for control of rejection in liver transplantation.

Authors:  W J Wall; C N Ghent; A Roy; V C McAlister; D R Grant; P C Adams
Journal:  Dig Dis Sci       Date:  1995-01       Impact factor: 3.199

Review 7.  Prevention and treatment of severe hemodynamic compromise in pediatric heart transplant patients.

Authors:  John M Costello; Elfriede Pahl
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.